| http://www.w3.org/ns/prov#value | - lfonic acid, p-toluenesulfonic acid and the like. [0035] Compounds of this invention are NK-1 receptor antagonists and, as such, are particularly useful for treating depression and pain, especially that resulting from inflammatory conditions such as migraine, rheumatoid arthritis, asthma, and inflammatory bowel disease or resulting from central nervous system (CNS) disorders such as Parkinson's di
|
